| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 98,293 | 86,350 | 63,536 | 56,915 | | Cost of Revenue | 49,478 | 43,177 | 40,503 | 41,070 | | | Gross Profit | 48,815 | 43,173 | 23,033 | 15,845 | | | Operating Expenses | | Research Development | 6,569 | 5,423 | 5,520 | 6,190 | | Selling General and Administrative | 11,468 | 11,745 | 12,138 | 12,154 | | Non Recurring | 360 | 1,996 | 1,177 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,418 | 24,009 | 4,198 | (2,499) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14 | 614 | (12) | (81) | | Earnings Before Interest And Taxes | 30,432 | 24,623 | 4,186 | (2,580) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 30,432 | 24,623 | 4,186 | (2,580) | | Income Tax Expense | (6,393) | 5,260 | 992 | (2,406) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 24,478 | 19,363 | 3,194 | (174) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (215) | 3 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 24,478 | 19,363 | 2,979 | (171) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $24,478 | $19,363 | $2,979 | ($171) |
|
0.29% Nasdaq 
Income Statement
